Enjoy 4 Concurrent Conferences free with One Registered Pass
BIT's 1st International Congress of
Gynaecology and Obstetrics
BIT's 4th Annual International
Congress of Cardiology-2012
BIT's 5th Annual World Congress of
Regenerative Medicine & Stem Cell

Event Report

On December 2-4, 2012, BIT's 2nd World Congress of MolMed-2012 was held successfully in Guangzhou, China.

Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development of molecular medicine.

As the keynote speakers, Dr. James B. Hicks, Research Professor and Director, Cold Spring Harbor Laboratory, USA; Dr. Hemchandra M. Shertukde, President, Diagnostic Devices Inc., USA; Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada; Dr. Karen Long, VP, Abbott Molecular Inc., USA; Dr. Peng Zhou, CSO, Rheonix, Inc., USA made excellent presentations and warmly discussed with the audiences at keynote forum.

Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing MolMed-2013 which would be better and more successful than MolMed-2012.                  


Introduction of MolMed-2012

Molecular medicine has provided unprecedented interdisciplinary approaches for a better understanding of molecular mechanisms of disease and translates into better approaches to prevention, diagnosis, and therapy, which embraces all aspects of human biology and pathophysiology. This congress will cover recent progress and precision in two parallel Conferences and Exposition in the areas of Molecular Diagnostics and Biomarkers. The dynamic programs will allow our colleagues to catch current progresses in prevention, diagnosis and treatment of human diseases along with the trends of the global business development in the areas

★ Highlights of the Conference

  • Organize up to 200+ Oral Presentations on the Latest Tech Trend of Molecular Medicine Development
  • Bring together 100+ Project Posters on New Technologies Implemented in Industrial Manufacturing
  • Network with 300+ Colleagues and Friends in China and Beyond
  • Meet with 30+ Leading Suppliers from all over the World
  • To Accelerate Progress in the Development of Molecular Medicine
  • Gain Valuable Career Development Advice/knowledge
  • Tech Tour to Famous Science Spots & Historical Sites in China

Renowned Speakers

Dr. James B. Hicks, Research Professor and Director, Cancer Genetics at Cold Spring Harbor Laboratory, USA

Dr. Sharon Correia,
Director, BioScale, Inc, USA

Dr. John Hurrell,
President, Focus Diagnostics at Quest Diagnostics Inc., USA

Dr. Lawrence J. Berliner,
Professor, University of Denver, USA


Dr. Andrea Gabrielli,
Professor, University of Florida, USA

Mr. Robert Bencher,
Director, Rules-Based Medicine Inc., USA
Dr. Hemchandra M. Shertukde, President, Diagnostic Devices Inc., USA Dr. Greg Maguire, Co-Founder and CEO, A & G Skin Solutions,Inc, USA

Dr. Saeed R. Khan,
Professor, University of Florida College of Medicine, USA

Dr. Daniel Ness,
Senior Director, Elan Pharmaceuticals, Inc., USA

Dr. Mahmood Moshiri,
President/CEO, Panacea Global Inc, Canada
Dr. Richard M. Weinshilboum,
Professor, Mayo Clinic College of Medicine, USA
Dr. Gyorgy Abel,
Medical Director, Lahey Clinic , USA
Dr. Thomas Braun,
CEO, Verisante Technology, Inc., Canada
Dr. Patrice P. Denèfle,
Vice President, Ipsen, France
Dr. Pamela L. Swatkowski,
Director, Abbott Molecular, Inc., USA
Dr. Charlotte A. Gaydos,
Professor, Johns Hopkins University School of Medicine, USA
Dr. Bojana Turic,
President and CEO, Perceptronix Medical Inc., USA
Dr. Daniel O’Shannessy,
Director, Diagnostics Development, Morphotek, Inc., USA
Dr. Gudrun Moore,
Professor, University College London, UK

Dr. Xiao Zeng,
Vice President, Global R & D, Qiagen Inc., USA

Past Event Report

BIT's 2nd Annual Congress of Biomarkers

BIT’s 4th Annual Congress and Exposition of
Molecular Diagnostics (CEMD-2011)
On November 7-9, 2011, BIT's 2nd Annual Congress of Biomarkers was held successfully in Beijing, ChinaMore...

BIT’s 4th Annual Congress and Exposition of Molecular Diagnostics (CEMD-2011) was successfully held on Sep. 22-24, 2011, in Beijing International Convention Center, China, with a theme of Overcome Misinterpretation of Symptoms.



Hosting Organization

Operating Organization

BIT Congress Inc.
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

Media Partners

© 2012-2013 All right reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897